Oerth's unique PROTAC® protein degradation technology is expected to be a new, game-changing generation of more sustainable crop protection products / The agreement recommits to the combination of ...
"This publication represents the culmination of years of foundational science at Oerth and a major validation of our ability to design protein degraders with a high level of precision. It's a pivotal ...
DURHAM – In launching Oerth Bio under the direction of CEO John Dombrosky, who formerly led the AgTech Accelerator in RTP, Bayer and partner Arvinas outlined an aggressive agtech agenda. The company, ...
Rev. Dr. Franz E. Oerth, died on Tuesday, Aug. 21. Dr. Oerth was a resident of Windsor Park Manor. Dr. Oerth was born and raised in Philadelphia, PA and graduated with high honors from Boys High ...
DURHAM, N.C.--(BUSINESS WIRE)--Oerth Bio (pronounced “Earth”), an agricultural biotech company pioneering targeted protein modulation for plant health applications, has appointed Thong Q. Le as an ...
DURHAM, N.C.--(BUSINESS WIRE)--Oerth Bio (pronounced “Earth”), an agricultural biotech company, today announced that Chris Otey, PhD, MBA, has joined the company as Chief Technology Officer, and Laura ...
DURHAM – Oerth Bio, a recently launched agriculture-focused biotech firm backed by Bayer with $55 million in funding is expanding its leadership team with three new hires. Pronounced “Earth,” Oerth ...
Bayer is launching a collaboration with Oerth Bio, a company Bayer founded in 2019 with the biotech firm Arvinas, which is using protein degradation technology in medicine. Oerth Bio plans to employ ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Durham biotech has set the ...
Rev. Dr. Franz E. Oerth, died on Tuesday, Aug. 21. Dr. Oerth was a resident of Windsor Park Manor. Dr. Oerth was born and raised in Philadelphia, PA and graduated with high honors from Boys High ...
Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Two decades ago, the American biochemists Craig Crews and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback